Innate Pharma (the “Company” - Euronext Paris: FR0010331421 – IPH) announces today that it will participate to the “Life Science Day”, a conference organized by NYSE-Euronext and France Biotech, and dedicated to meetings between biotechnology companies listed on NYSE-EURONEXT and investors. This day will take place on November 9, 2010, in Paris, France.
During this event, Hervé Brailly, CEO of Innate Pharma, will present the Company, its development strategy and its latest news.
Innate Pharma will also participate to the coming investor conferences:
- “Healthcare & Biotechnology Conference” organized by Société Générale, in Paris on February 9, 2011
- “CF&B Smallcap Event”, in Paris on April 25 and 26, 2011
| PR in English | 34.43 KB |
| CP en français | 34.52 KB |